The efficacy of nasal airway stent (nastentTM) in patient with obstructive sleep apnea

The efficacy of nasal airway stent (nastentTM) in patient with obstructive sleep apnea - Nastent study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024617

Enrollment

Registered

2016-11-04

Start date

2016-11-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea

Interventions

Nastent treatment (1 month)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have been diagnosed with obstructive sleep apnea

Exclusion criteria

Exclusion criteria: Patients who have a neuromuscular disease, severe heart disease and mental disease.

Design outcomes

Primary

Measure	Time frame
The change of apnea hypopnea index (AHI) after one month treatment of nastent.	—

Secondary

Measure	Time frame
The change of minimum SpO2 after one month treatment of nastent.	—

Countries

Japan

Contacts

Public ContactKentaro Okuno

Osaka University Dental Hospital Division for Oral and Facial Disorders

k-okuno@dent.osaka-u.ac.jp06-6879-2278

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026